Remote vs. In-person Schooling during the COVID-19 Pandemic and Internalizing Symptoms among Children on the Autism Spectrum.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101300021 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1750-9467 (Print) NLM ISO Abbreviation: Res Autism Spectr Disord Subsets: PubMed not MEDLINE
    • Publication Information:
      Original Publication: Amsterdam : Elsevier
    • Abstract:
      Background: Children on the autism spectrum encountered interruptions to their education due to the COVID-19 pandemic (White et al., 2021). This study examined the extent to which autistic children's anxiety and depressive symptoms during the pandemic were associated with the school format they attended in October 2020 (remote, in-person/hybrid, homeschool), controlling for their pre-pandemic symptoms. Pre-pandemic peer victimization and autism symptom characteristics were tested as moderators.
      Method: Participants were 81 verbally-fluent autistic children ( M age = 14.71 years, 77.8% males), without an intellectual disability, and their mothers; families were part of an ongoing, longitudinal study that began before the pandemic.
      Results: School format did not significantly predict children's anxiety or depressive symptoms. Results indicated that the only significant predictors of children's anxiety and depressive symptoms during the pandemic were their pre-pandemic symptom levels.
      Conclusions: School format did not significantly contribute to variability in children's anxiety and depressive symptoms during the pandemic, over and above their pre-pandemic symptoms. The results contribute quantitative findings to the growing body of research on pandemic-related effects on autistic children, and underscore the need to account for pre-pandemic child functioning when drawing conclusions about pandemic-level effects.
      Competing Interests: Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
    • References:
      J Abnorm Child Psychol. 2003 Feb;31(1):13-27. (PMID: 12597696)
      MMWR Morb Mortal Wkly Rep. 2021 Mar 19;70(11):369-376. (PMID: 33735164)
      Psychol Bull. 2005 Jul;131(4):483-509. (PMID: 16060799)
      J Pediatr Psychol. 2021 Jun 3;46(5):514-525. (PMID: 33758930)
      J Autism Dev Disord. 2021 Oct;51(10):3766-3773. (PMID: 33387233)
      Lancet Psychiatry. 2020 Jun;7(6):481-483. (PMID: 32445682)
      J Autism Dev Disord. 2016 Nov;46(11):3557-3566. (PMID: 27565652)
      JAMA Netw Open. 2021 Sep 1;4(9):e2124092. (PMID: 34477850)
      J Abnorm Child Psychol. 1996 Dec;24(6):749-65. (PMID: 8970908)
      Eur Child Adolesc Psychiatry. 2023 Jun;32(6):995-1013. (PMID: 35962147)
      Int J Environ Res Public Health. 2023 Jan 04;20(2):. (PMID: 36673705)
      J Intellect Disabil Res. 2020 Oct;64(10):739-749. (PMID: 32808424)
      J Clin Child Psychol. 2001 Dec;30(4):479-91. (PMID: 11708236)
      J Autism Dev Disord. 2017 Dec;47(12):3822-3832. (PMID: 27328680)
      Res Dev Disabil. 2021 Mar;110:103860. (PMID: 33486395)
      J Autism Dev Disord. 2021 Aug;51(8):2920-2928. (PMID: 33090358)
      Child Adolesc Psychiatry Ment Health. 2020 May 12;14:20. (PMID: 32419840)
      Int J Environ Res Public Health. 2021 Jan 25;18(3):. (PMID: 33504101)
      Mol Autism. 2021 Mar 3;12(1):21. (PMID: 33658046)
      J Autism Dev Disord. 2021 May;51(5):1772-1780. (PMID: 32737668)
      Res Autism Spectr Disord. 2014 Sep 1;8(9):1225-1234. (PMID: 25147580)
      J Am Acad Child Adolesc Psychiatry. 1999 Oct;38(10):1230-6. (PMID: 10517055)
      J Autism Dev Disord. 2023 Apr;53(4):1642-1672. (PMID: 35013867)
      J Autism Dev Disord. 2019 Feb;49(2):750-761. (PMID: 30238180)
      J Child Psychol Psychiatry. 2011 Jan;52(1):80-90. (PMID: 20662993)
      J Autism Dev Disord. 2023 Jul;53(7):2921-2927. (PMID: 35113328)
      J Autism Dev Disord. 2022 Jan;52(1):392-401. (PMID: 33704613)
      Autism. 2023 Jan;27(1):105-116. (PMID: 35669991)
      Autism Res. 2021 Oct;14(10):2113-2119. (PMID: 34231323)
      Autism Res. 2021 Dec;14(12):2477-2494. (PMID: 34591373)
      Public Health Pract (Oxf). 2020 Nov;1:100034. (PMID: 34173571)
      Front Psychiatry. 2020 Nov 16;11:561882. (PMID: 33304279)
      Behav Res Methods. 2007 May;39(2):175-91. (PMID: 17695343)
      J Affect Disord. 2022 Jan 1;296:567-576. (PMID: 34600966)
      Autism. 2023 Jan;27(1):188-199. (PMID: 35669990)
      Autism Adulthood. 2020 Jun 1;2(2):106-117. (PMID: 36601566)
      Eur Child Adolesc Psychiatry. 2022 Apr;31(4):649-661. (PMID: 33415470)
      J Autism Dev Disord. 2023 Oct;53(10):3968-3979. (PMID: 35945387)
      Qual Life Res. 2010 May;19(4):595-607. (PMID: 20213516)
      Child Adolesc Ment Health. 2020 Nov;25(4):263-264. (PMID: 33058519)
    • Grant Information:
      R15 HD094279 United States HD NICHD NIH HHS
    • Contributed Indexing:
      Keywords: COVID-19 pandemic; anxiety; autism spectrum disorder; depressive symptoms; remote schooling
    • Publication Date:
      Date Created: 20231127 Latest Revision: 20231129
    • Publication Date:
      20231215
    • Accession Number:
      PMC10673621
    • Accession Number:
      10.1016/j.rasd.2023.102284
    • Accession Number:
      38009124